OREANDA-NEWS. July 04, 2012. JSC Pharmstandard announces the acquisition of 50.1% stake in BIGPEARL TRADING LIMITED (Cyprus).

In February,2012 Russia's Federal Antimonopoly Service (FAS) has granted approval for OJSC Pharmastand's bid to acquire 50.1% of the voting shares of Cyprus-based Bigpearl Trading Limited.

The main sphere of activity of the enterprises comprising the Pharmstandard group of companies, are developing and manufacturing of high-quality modern pharmaceutical products which meet the requirements of the healthcare system and the expectations of patients.

The most well known Pharmstandard products today are Arbidol®, Complivit®, Pentalgin®, Flucostat®, Phosphoglive®, Amixin®, Afobazol®, Rastan® and Biosulin®. The Pharmstandard group of companies manufactures more than 250 pharmaceutical products, including medicines for the treatment of cardio-vascular diseases, diabetes, growth hormone deficiency, gastroenterological, neurological, contagious diseases, metabolic disorders, cancer and other diseases. More than 100 Pharmstandard products (taking into account all forms and dosages) are included in the list of Vital and Essential Pharmaceuticals.